Solek J, Braun M, Sadej R, Romanska H
Int J Oncol. 2024; 65(4).
PMID: 39219285
PMC: 11374155.
DOI: 10.3892/ijo.2024.5682.
Han S, Tian Z, Tian H, Han H, Zhao J, Jiao Y
Cell Death Discov. 2023; 9(1):181.
PMID: 37301856
PMC: 10257651.
DOI: 10.1038/s41420-023-01476-0.
Liang X, Tang Z, Zhang Y, Sun Y, Wang J
Acta Biochim Biophys Sin (Shanghai). 2022; 54(9):1234-1243.
PMID: 36148951
PMC: 9828316.
DOI: 10.3724/abbs.2022124.
Zhu X, Xie Y, Huang W, Chen Z, Guo S
BMC Cancer. 2022; 22(1):339.
PMID: 35351053
PMC: 8962469.
DOI: 10.1186/s12885-022-09356-z.
Liu S, Zhang Y, Cui S, Song D, Li B, Chen Q
Cancer Cell Int. 2021; 21(1):605.
PMID: 34774047
PMC: 8590370.
DOI: 10.1186/s12935-021-02301-3.
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway.
Qiu L, Ma Y, Chen X, Zhou L, Zhang H, Zhong G
J Transl Med. 2021; 19(1):344.
PMID: 34376200
PMC: 8353798.
DOI: 10.1186/s12967-021-03021-y.
NAP1L1 Functions as a Tumor Promoter Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
Zhang Y, Chen Q, Li B, Li H, Zhao X, Xiao Y
Front Cell Dev Biol. 2021; 9:659680.
PMID: 34368121
PMC: 8343235.
DOI: 10.3389/fcell.2021.659680.
HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer.
Eguchi R, Wakabayashi I
Oncol Rep. 2020; 44(1):14-28.
PMID: 32319650
PMC: 7251661.
DOI: 10.3892/or.2020.7580.
Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
Zhang C, Chang X, Chen D, Yang F, Li Z, Li D
Cancer Manag Res. 2019; 11:7909-7923.
PMID: 31692549
PMC: 6710542.
DOI: 10.2147/CMAR.S215341.
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Jiang H, Fu Q, Song X, Ge C, Li R, Li Z
Oncol Lett. 2019; 18(5):4936-4946.
PMID: 31612005
PMC: 6781745.
DOI: 10.3892/ol.2019.10812.
LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
Ma Q, Qi X, Lin X, Li L, Chen L, Hu W
Hum Cell. 2019; 33(1):232-242.
PMID: 31586299
DOI: 10.1007/s13577-019-00287-9.
Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.
Chu T, Huang S, Yang S, Li C, Lin H, Weng B
Oncogene. 2019; 38(37):6461-6477.
PMID: 31332288
DOI: 10.1038/s41388-019-0886-3.
Effect of Skeletal Paracrine Signals on the Proliferation of Interzone Cells.
Thampi P, Dubey R, Lowney R, Adam E, Janse S, Wood C
Cartilage. 2019; 13(2_suppl):82S-94S.
PMID: 31023058
PMC: 8804777.
DOI: 10.1177/1947603519841680.
The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.
Kazeminezhad B, Baradaran B, Ahmadi M
J Family Med Prim Care. 2018; 6(4):770-774.
PMID: 29564261
PMC: 5848396.
DOI: 10.4103/jfmpc.jfmpc_177_17.
Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.
Yang Y, Liang S, Li Y, Gao F, Zheng L, Tian S
Oncol Lett. 2018; 14(6):7179-7184.
PMID: 29344149
PMC: 5754909.
DOI: 10.3892/ol.2017.7180.
Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
Yang F, Yu N, Wang H, Zhang C, Zhang Z, Li Y
PLoS One. 2018; 13(1):e0190725.
PMID: 29300772
PMC: 5754131.
DOI: 10.1371/journal.pone.0190725.
The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.
LeBlanc M, Wang W, Chen X, Ji Y, Shakya A, Shen C
Mol Vis. 2016; 22:374-86.
PMID: 27122967
PMC: 4842004.
The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
Tang J, Shi H, Li H, Zhen T, Dong Y, Zhang F
Tumour Biol. 2016; 37(8):10287-301.
PMID: 26842923
DOI: 10.1007/s13277-016-4905-5.
The expression and clinical significance of HDGF in osteosarcoma.
Chen Z, Qiu S, Lu X
Onco Targets Ther. 2015; 8:2509-17.
PMID: 26392778
PMC: 4574856.
DOI: 10.2147/OTT.S91708.
Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J, Tang J, Shi H, Li H, Zhen T, Xie W
Oncotarget. 2015; 6(30):29357-74.
PMID: 26296979
PMC: 4745732.
DOI: 10.18632/oncotarget.4982.